We unlock the power of neuroscience to ease suffering and enhance human potential. We’re on a mission to transform the way the world treats neurological problems with effective, accessible and non-pharmaceutical solutions that harness the latest in science, technology, engineering and big data.
Our proprietary Axon system employs electroencephalography (EEG) neurofeedback and combines miniaturised technology, Cloud-based AI and consumer-friendly apps to enable patients to self-treat pain and other neurological conditions at home or in a professional setting. Axon works by monitoring brain activity and then helping the patient retrain their brain to interpret nerve signals in a different way.
Exsurgo is rapidly expanding the global database of quality clinical trials and studies to confirm the effectiveness of its technologies for a range of neurologically-related conditions, prior to commercial rollout.
Earlier in December, I had the privilege of joining an innovative Kiwi
New Zealand neuroscience company Exsurgo has appointed experienced biomedical scientist and researcher
Hundreds of thousands of lives have been ruined or lost as a
Christine Ozolins, Chief Science Officer at Exsurgo, recently featured on the My
Chronic neuropathic pain after surgery is a significant clinical problem (Borsook et al 2013). People with this pain condition may experience shooting, burning pain, numbness or pins and needles, or hypersensitivity to pain. The pain may be constant or may occur intermittently. Unlike most other types of pain, neuropathic pain does not usually get better with common painkillers, such as paracetamol and ibuprofen. Other medicines commonly used include anti-depressants and anti-convulsant.
Two patients with chronic neuropathic pain following back operations successfully used the Axon intervention to reduce pain and increasing mobility.